EBV-Related Leiomyosarcoma
1 clinical trials · Condition
◉ Watch EBV-Related Leiomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC (NCT05166577) | Viracta Therapeutics, Inc. | 2021-10-08 |
Track EBV-Related Leiomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.